:quality(80)/cdn-kiosk-api.telegraaf.nl/c39bbdb2-e04a-11ea-a86d-0255c322e81b.jpg?fit=%2C&ssl=1)
:quality(50)/cdn-kiosk-api.telegraaf.nl/c39bbdb2-e04a-11ea-a86d-0255c322e81b.jpg)
—-
Amsterdam – Biotechnology company Kiadis Pharma is starting a study with partners into the treatment of Covid-19, the disease caused by the corona virus. It uses so-called Natural Killer cells (NK cells), large white blood cells that form the first line of defense in the human immune system against cancer cells and infections.
–
Related posts:
Beijing Develops Plan to Contain Monkeypox Amidst Rising Cases
Doctor Manoon reveals "COVID-19" is on the rise. Back to overtaking influenza
Every hot dog you eat reduces your life expectancy by 36 minutes, according to a new study - Diet & ...
The heart ... pump of blood and emotional memory - Targatocn.it
